Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines

por Welch, Darcy, Kahen, Elliot, Fridley, Brooke, Brohl, Andrew S., Cubitt, Christopher L., Reed, Damon R.
Publicado 2019

Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma

por Kahen, Elliot, Yu, Diana, Harrison, Douglas J., Clark, Justine, Hingorani, Pooja, Cubitt, Christopher L., Reed, Damon R.
Publicado 2016

CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo

por Turner, Joel G., Dawson, Jana, Emmons, Michael F., Cubitt, Christopher L., Kauffman, Michael, Shacham, Sharon, Hazlehurst, Lori A., Sullivan, Daniel M.
Publicado 2013

Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma

por Yu, Diana, Kahen, Elliot, Cubitt, Christopher L., McGuire, Jeremy, Kreahling, Jenny, Lee, Jae, Altiok, Soner, Lynch, Conor C., Sullivan, Daniel M., Reed, Damon R.
Publicado 2015

Rapid Screening of Novel Agents for Combination Therapy in Sarcomas

por Cubitt, Christopher L., Menth, Jiliana, Dawson, Jana, Martinez, Gary V., Foroutan, Parastou, Morse, David L., Bui, Marilyn M., Letson, G. Douglas, Sullivan, Daniel M., Reed, Damon R.
Publicado 2013

Long-Term CD4(+) T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study

por Gallen, Corey, Dukes, Christopher W., Aldrich, Amy, Macaisa, Lauren, Mo, Qianxing, Cubitt, Christopher L., Pilon-Thomas, Shari, Giuliano, Anna R., Czerniecki, Brian J., Costa, Ricardo L. B.
Publicado 2022

Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors

por Kahen, Elliot John, Brohl, Andrew, Yu, Diana, Welch, Darcy, Cubitt, Christopher L., Lee, Jae K., Chen, Yunyun, Yoder, Sean J., Teer, Jamie K., Zhang, Yonghong O., Wallace, Margaret R., Reed, Damon R.
Publicado 2018

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients

por Giuliano, Anna, Kuter, Barbara, Pilon‐Thomas, Shari, Whiting, Junmin, Mo, Qianxing, Leav, Brett, Sirak, Bradley, Cubitt, Christopher, Dukes, Christopher, Isaacs‐Soriano, Kimberly, Kennedy, Kayoko, Ball, Somedeb, Dong, Ning, Jain, Akriti, Hwu, Patrick, Lancet, Jeffrey
Publicado 2023

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

por MARCHION, DOUGLAS C., BICAKU, ELONA, XIONG, YIN, ZGHEIB, NADIM BOU, SAWAH, ENTIDHAR AL, STICKLES, XIAOMANG BA, JUDSON, PATRICIA L., LOPEZ, ALEX S., CUBITT, CHRISTOPHER L., GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M., APTE, SACHIN M., BERGLUND, ANDERS, LANCASTER, JOHNATHAN M.
Publicado 2013

Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida

por Giuliano, Anna R., Lancet, Jeffrey E., Pilon-Thomas, Shari, Dong, Ning, Jain, Akriti G., Tan, Elaine, Ball, Somedeb, Tworoger, Shelley S., Siegel, Erin M., Whiting, Junmin, Mo, Qianxing, Cubitt, Christopher L., Dukes, Christopher W., Hensel, Jonathan A., Keenan, Robert J., Hwu, Patrick
Publicado 2022

SARS-CoV-2 antibody response duration and neutralization following natural infection

por Dukes, Christopher W, Rossetti, Renata AM, Hensel, Jonathan A, Snedal, Sebastian, Cubitt, Christopher L, Schell, Michael J, Abrahamsen, Martha, Isaacs-Soriano, Kimberly, Kennedy, Kayoko, Mangual, Leslie N, Whiting, Junmin, Martinez-Brockhus, Veronica, Islam, Jessica Y, Rathwell, Julie, Beatty, Matthew, Hall, Amy M, Abate-Daga, Daniel, Giuliano, Anna R, Pilon-Thomas, Shari
Publicado 2023